We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $461M
1-Year Est. Return 33.26%
This Fund
S&P 500
This Quarter Est. Return
-6.78%
1 Year Est. Return
+33.26%
3 Year Est. Return
+35.29%
5 Year Est. Return
+56.36%
10 Year Est. Return
+229.32%
AUM
$291M
AUM Growth
-$38.7M
Cap. Flow
-$14.6M
Cap. Flow %
-5.02%
Top 10 Hldgs %
61.24%
Holding
33
New
4
Increased
8
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$12.1M
2
PFE icon
Pfizer
PFE
+$9.09M
3
AMGN icon
Amgen
AMGN
+$8.9M
4
CNC icon
Centene
CNC
+$4.68M
5
ELAN icon
Elanco Animal Health
ELAN
+$3.62M

Sector Composition

Rank Sector Weight
1 Healthcare 99.18%
2 Miscellaneous 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$5.78B
$2.95M 1.01%
+65,250
New +$2.79M
THC icon
27
Tenet Healthcare
THC
$21.3B
$2.78M 0.95%
22,000
-4,361
-17% -$648K
LNTH icon
28
Lantheus
LNTH
$6.59B
$2.3M 0.79%
25,712
-6,000
-19% -$584K
LEGN icon
29
Legend Biotech
LEGN
$4.19B
$1.58M 0.54%
48,495
+9,733
+25% +$403K
AGIO icon
30
Agios Pharmaceuticals
AGIO
$1.98B
-67,908
Closed -$3.02M
ALKS icon
31
Alkermes
ALKS
$7.73B
-100,000
Closed -$2.8M
UHS icon
32
Universal Health Services
UHS
$10B
-17,627
Closed -$4.04M

Similar funds

Sector Gamma AS's Q4 2024 Portfolio in Review

As of Q4 2024, Sector Gamma AS held 33 positions worth $291M, down 12% from $330M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sector Gamma AS withdrew a net $14.6M in Q4 2024, closing 3 positions and reducing 15 holdings. Its most notable exit was Universal Health Services, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

Against the trend, Sector Gamma AS opened a new position in Johnson & Johnson worth $11.3M.

  • Sector Gamma AS's largest Q4 2024 buy was Johnson & Johnson: 78,000 shares worth $11.3M.
  • Sector Gamma AS added most to Pfizer in Q4 2024, an estimated $9.09M increase.
  • Sector Gamma AS's biggest Q4 2024 reduction was Bristol-Myers Squibb, cutting an estimated $13.2M.
  • Sector Gamma AS fully exited Universal Health Services in Q4 2024, selling an estimated $4.04M.
  • Sector Gamma AS's ten largest holdings make up 61% of its $291M portfolio in Q4 2024.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q4 2024.
  • Sector Gamma AS's portfolio value fell 12% quarter-over-quarter to $291M.

Based on Sector Gamma AS's 13F filing for Q4 2024, filed 11 Feb 2025.